Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.
Agri-Tech Pionee | Corteva leads agricultural innovation with hybrid wheat, biofuels, and gene editing technologies, driving growth through 2027 and beyond |
Market Dominance | Explore Corteva's strong position in seeds and crop protection, with $16.83B annual revenue and strategic focus on high-growth areas and emerging markets |
Financial Resilience | Delve into Corteva's solid performance despite challenges, with projected operational EBITDA of $3.6-3.8B for 2025 and long-term double-digit CAGR |
Analyst Outlook | Discover varied analyst perspectives, with price targets ranging from $58 to $74, reflecting confidence in Corteva's growth potential and market leadership |
Metrics to compare | CTVA | Sector Sector - Average of metrics from a broad group of related Basic Materials sector companies | Relationship RelationshipCTVAPeersSector | |
---|---|---|---|---|
P/E Ratio | 34.7x | 21.5x | 0.3x | |
PEG Ratio | 0.56 | 0.08 | 0.00 | |
Price/Book | 2.0x | 1.1x | 1.6x | |
Price / LTM Sales | 3.0x | 0.6x | 1.3x | |
Upside (Analyst Target) | 12.3% | 13.9% | 17.2% | |
Fair Value Upside | Unlock | 7.4% | 0.0% | Unlock |